$19.11
0.68% today
NYSE, Dec 30, 10:10 pm CET
ISIN
US29415F1049
Symbol
NVST

Envista Holdings Corp Stock News

Neutral
PRNewsWire
about one month ago
BREA, Calif. , Nov. 20, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2023 Sustainability Report, outlining its continued efforts to integrate environmental, social, and governance (ESG) considerations into its mission to digitize, personalize, and democratize dental care.
Neutral
PRNewsWire
about one month ago
BREA, Calif. , Nov. 19, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in a fireside chat at the Evercore HealthCONx Conference on Tuesday, December 3, 2024 from 12:30 – 1:15 pm ET at the Loews Coral Gables Hotel in Coral Gables, Florida.
Neutral
Seeking Alpha
2 months ago
Envista Holdings Corporation (NYSE:NVST ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Amit Bhagwat - VP of IR Paul Keel - CEO Eric Hammes - CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Jeff Johnson - Robert W. Baird & Co. Erin Wright - Morgan Stanley & Co. Jon Block - Stifel, Nicolaus & Company Michael Cherney - Leerink Partners Kevin ...
Neutral
PRNewsWire
2 months ago
BREA, Calif. , Oct. 30, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter of 2024.
Neutral
PRNewsWire
3 months ago
BREA, Calif. , Oct. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2024 on Wednesday, October 30, 2024.
Neutral
PRNewsWire
4 months ago
BREA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2024 Global Healthcare Conference on Wednesday, September 11, 2024 from 10:50 – 11:20 am ET at the InterContinental New York Barclay.
Positive
Seeking Alpha
5 months ago
Envista Holdings Corporation published Q2 2024 earnings results, highlighting a $1.2 billion non-cash charge from impairments. I find their valuation metrics quite attractive, comparing favorably to both the healthcare sector and their 5-year historical averages. Despite recent challenges, the company continues to generate positive free cash flows.
Neutral
Seeking Alpha
5 months ago
Envista Holdings Corporation (NYSE:NVST ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Stephen Keller - Principal Financial Officer Paul Keel - CEO Eric Hammes - Incoming CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Erin Wright - Morgan Stanley & Co. Jon Block - Stifel, Nicolaus & Company Jeff Johnson - Robert W. Baird & Co. Brandon Vazqu...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today